Home › Myelodysplastic Syndromes › Pennsylvania › Pittsburgh
Myelodysplastic Syndromes clinical trials in Pittsburgh, PA
9 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Collection of Tissue Samples for Cancer Research
RecruitingObservational study
- University of Pittsburgh Medical Center, Pittsburgh
A Study of BGB-11417 in Participants With Myeloid Malignancies
RecruitingPhase 1/2
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
RecruitingPhase 1
- UMPC Hillman Cancer Center, Pittsburgh
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Allegheny Health Network, Pittsburgh
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RecruitingPhase 2
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX44 studies
- Baldwin Park, CA26 studies
- New York City, NY21 studies
- Seattle, WA21 studies
- Washington, DC20 studies
- Boston, MA20 studies
- Tampa, FL19 studies
- Miami, FL17 studies
- Columbus, OH14 studies
- Durham, NC14 studies
- St. Louis, MO14 studies
- Chicago, IL14 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer38 studies
- Colorectal Cancer32 studies
- Ovarian Cancer31 studies
- Melanoma31 studies
- Metastatic Cancer31 studies
- Endometrial Cancer24 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Depression22 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.